RESEARCH DOSSIER
Motor Bodily Injury Claim Assessment and Settlement
Abstract. Motor bodily injury claim assessment is the process by which injury, causation, entitlement, compensable loss, payment responsibility, and settlement consequences are established after a road crash. The subject combines clinical evidence, legal liability, insurance contracts, economic valuation, claims administration, and the claimant's experience of obtaining compensation. Its practical importance is substantial because decisions on what constitutes a compensable injury, how future consequences are projected, when a settlement becomes final, and whose information is trusted jointly determine the distribution of resources after traffic injury. This research dossier investigates six questions: how bodily injury evidence is organized; how expenses, earnings loss and non-economic harm are valued; how representation and delay influence observed claims; what makes an offer sufficient and a discharge informed; how institutional arrangements differ internationally; and how empirical researchers can distinguish causal effects from selection and measurement artifacts. The analysis examines World Health Organization injury and functioning classifications; European Union motor-liability directives; compulsory insurance and compensation arrangements in Great Britain, New South Wales, Japan, and New Zealand; United States motor coverage categories; supervisory and accounting standards; and prospective studies of post-crash recovery and claim closure. The comparative evidence establishes that medical stabilization, valuation readiness, offer, payment and legal closure are separate dates, and that a closed claim is an unreliable stand-alone measure of health recovery. The insurer's expected obligation, the legally recoverable amount, the claimant's immediate liquidity, and the net value of settlement are likewise distinct quantities. Numerical demonstrations are explicitly hypothetical and are not estimates of market-level loss severity. The original contribution is a structured synthesis of documented institutional differences, measurable settlement outcomes, and the identification problems in representation and closure research. No new theory, doctrine, or empirical causal discovery is claimed. The manuscript proposes auditable questions for future claims-data studies and gives a reproducible evidentiary and editorial record.
Keywords: Motor insurance; bodily injury claims; road traffic injury; compensable damages; medical evidence; causation; permanent impairment; wage loss; future care; claimant representation; settlement delay; claims closure; reasoned offer; compensation sufficiency; comparative insurance law; no-fault benefits; third-party liability; claimant fairness; claims reserving; evidence validation.
Introduction
The settlement of motor bodily injury claims is one of the points at which a road crash becomes an economic, legal, and administrative event. A collision may injure a driver, passenger, cyclist, pedestrian, motorcyclist, or other road user. The resulting claim must connect the event to particular bodily consequences, identify the paying institution, establish legal or statutory eligibility, determine present and future losses, and select a payment or resolution procedure. The eventual settlement transfers money or benefits and can terminate contested rights. Each part requires a different form of knowledge. Emergency medical records describe clinical states; rehabilitation reports describe functional capacity; employment records support earnings calculations; crash records help identify the relevant event and potential responsibility; contracts and legislation determine insurance or statutory entitlements; and actuarial data describe uncertain settlement patterns at portfolio level.
The WHO road-safety assessment estimated approximately 1.19 million annual road-traffic deaths in its 2023 report, which primarily assesses the 2010–2021 period. Fatality counts describe only one component of the injury burden. They cannot be used to infer the incidence of insured bodily injury claims, the mean claim size, or the cost of a particular insurance scheme without separate exposure, reporting, coverage and compensation data. This distinction matters in international comparison: traffic injury may occur without an insurance claim, while an accident may produce several claims with different contractual and statutory pathways.
The NAIC explanation of auto coverages distinguishes third-party bodily injury liability, medical payments, personal injury protection, and uninsured or underinsured motorist arrangements in United States markets. These insurance categories may finance related economic consequences under different triggers and limits. In Europe, Directive 2009/103/EC establishes motor-liability insurance protections and important victim recourse procedures. In Japan, the compulsory automobile liability system has specified per-victim bodily injury limits and a direct-claim mechanism. In New South Wales, current Motor Accident Guidelines regulate several parts of claim assessment and dispute handling. These regimes share a concern for injured persons while organizing valuation and payment in materially different ways.
This dossier is a comparative scientific monograph, not a jurisdiction-specific claims manual. The relevant legal rules are those in force for the relevant accident, policy, claimant and decision dates; an international comparison cannot supply a single universal damages formula. The analysis distinguishes directly observed findings from normative assessment, regulatory requirements from administrative recommendations, and empirical results from illustrative calculations. All linked studies and documents appear in the References and the machine-readable EVIDENCE.json. Date-sensitive instruments are identified by version or date. Where administrative datasets or individual insurer files are unavailable, the research specifies testable designs rather than treating hypothetical amounts as observed data.
Research questions and evidentiary method
The central research questions concern (i) measurement of injury and loss, (ii) mechanisms connecting representation, case complexity and delay, and (iii) the sufficiency and fairness of settlements under divergent entitlement systems. Primary legislation and supervisory guidance establish legal categories; official agency material describes administered benefit arrangements; published prospective research identifies observed associations and their limitations. The principal unit of analysis is the claimant–crash–coverage–jurisdiction combination, with different dates recorded for the accident, first medical contact, notice, initial evidence, liability decision, offer, payment, discharge and, separately, functional recovery.
The evidence hierarchy in this manuscript gives operative legal texts authority on statutory duties; regulator guidance authority on stated supervisory procedures; prospective cohort studies authority on their sampled associations; and original transparent calculations authority only within their assumptions. A journal association does not substitute for a causal intervention study; a regulatory guideline does not replace primary statute; and an accounting balance does not measure a particular person's adjudicated damages. These distinctions govern the results below.
Conceptual, Historical, and Primary-Source Foundations
From the road event to the claim obligation
A motor bodily injury claim originates in an injury-generating event and proceeds through several logically ordered questions. Was there an event in the relevant vehicle-use and territorial scope? Is there evidence of bodily or psychological injury? What causal connection is legally required between the event and injury? Which person or institution has the obligation to pay? What categories of damage or statutory benefit are allowed? What evidence supports the amount? Which agreement, adjudication or statutory process can finally discharge the obligation? These questions are interconnected but require separate findings.
Historically, compulsory motor insurance and public injury compensation grew as motor transport imposed risks on people who were not parties to the vehicle owner's insurance bargain. Contemporary systems address the resulting financial protection in different institutional forms. The Great Britain motor-insurance requirements under section 145 of the Road Traffic Act 1988 concern covered liability for death, bodily injury and property damage arising from specified vehicle use. Section 151 separately establishes a duty to satisfy qualifying judgments, subject to statutory conditions. The two provisions should be analyzed together while distinguishing compulsory policy scope from the enforceability of a claimant's judgment.
The EU framework expresses another institutional feature: Article 18 of Directive 2009/103/EC requires direct action by injured parties against the motor insurer covering the person responsible. Article 22 addresses settlement procedure and distinguishes quantified, uncontested liability from claims where liability or damages remain disputed. The directive does not itself give every claimant a uniform national damages award. Substantive civil-liability rules, procedural application, heads of damage, national court approaches and limitation regimes remain significant variables. Directive (EU) 2021/2118 amends the motor-insurance framework, including safeguards connected with insurer insolvency. Its transposition deadline and national implementation must be separated from the original date on which the amending instrument entered into force.
The Japanese CALI system overview states that compulsory automobile liability covers bodily injury rather than property damage, permits direct claims and provisional payments, and sets payment ceilings by injury category. The scheme's per-victim limits, such as ¥1.2 million for injury and up to ¥30 million for death, identify the statutory layer; voluntary cover or the personal liability of a tortfeasor may bear amounts above compulsory ceilings. A claim's total legal damages and the maximum payment from a particular source are therefore different quantities.
Insurance obligation, damages and benefit entitlement
The basic distinctions can be stated with explicit notation. Let H denote the documented health consequences of a crash, E the economic and non-economic losses proved under the applicable damages rules, L the legally recoverable damages after causation, liability and defenses, B the amount of statutory or first-party benefits, and I the insurer-funded amount available within coverage conditions and limits. H, E, L, B and I are different objects. Medical injury may be real while a liability claim is legally unavailable; a statutory benefit may be payable even when a traditional fault allegation is unresolved; a legally established loss may exceed the responsible policy's limit; and a claimant may receive benefits from more than one source subject to coordination and recovery rules.
The NAIC coverage taxonomy provides a useful example of this separation. Third-party bodily injury liability, uninsured motorist cover and personal injury protection can respond to different aspects of the same crash, depending on state law and policy language. An investigator must determine the insured relationship and priority of payments before adding cost streams. Double counting a hospital bill already satisfied by another payer, or overlooking a valid reimbursement lien, distorts settlement sufficiency.
The statutory structure in New Zealand illustrates a more extensive substitution of benefit entitlement for ordinary tort damages. Section 317 of the Accident Compensation Act 2001 limits proceedings independently of the Act for covered personal injury, subject to its express exceptions. This cited legislative view documents the provision; any case-specific application requires verification of the current consolidated text and the accident date. ACC's weekly-compensation eligibility guidance describes replacement of part of qualifying earnings while a covered injury prevents work. Because the claimant's remedy is organized around statutory benefits, a cross-country comparison of lump-sum motor settlements alone will systematically omit part of New Zealand's accident-injury provision.
A chronological structure of settlement
For a single claimant, define t0 as crash date, t1 as notification, t2 as completion of sufficient medical and economic evidence, t3 as the insurer's eligibility or liability decision, t4 as a settlement offer, t5 as acceptance, t6 as payment and t7 as final legal closure. These may occur out of order in practice: an interim benefit can precede complete prognosis, and some disputes concern the amount after responsibility has been accepted. Functional or clinical recovery has its own time variable, R, which need not equal any t1–t7.
It is useful to distinguish four durations: reporting delay t1−t0; evidentiary preparation t2−t1; decision and negotiation time t5−t2; and settlement implementation t7−t5. Each interval has different explanations and potential interventions. A claim may close quickly because it was simple, because treatment was completed, because a claimant needed cash, because legal expenses made litigation unattractive, or because a low offer was accepted under constrained information. Therefore speed is not a sufficient statistic for fairness. Conversely, a large future-care claim may appropriately remain open while medical evidence develops, although unreasonable administrative inactivity can make the same duration harmful.
Conduct requirements at the interface
The FCA claims-handling rule, ICOBS 8.1.1R, requires insurers within its scope to handle claims promptly and fairly, provide reasonable guidance and information to policyholders, refrain from unreasonable rejection, and settle promptly once terms are agreed. Its immediate legal addressee and application matter: a third-party injured claimant should not automatically be treated as the same category as the insurer's own policyholder for every rule. Still, the standard supplies a benchmark for examining the timing and transparency of insurance administration.
The IAIS Insurance Core Principles articulate insurance supervisory standards at an international level; they are supervisory guidance rather than self-executing damages statutes. For motor injury, their relevance lies in the expectation of fair treatment, sound claim handling and control of market conduct. National law and regulator instruments determine the operational enforcement mechanisms.
Medical Evidence and Bodily Injury Valuation
Injury, impairment, disability and participation
Medical evidence assessment begins by separating diagnosis, impairment, activity limitation, participation restriction, prognosis and the subjective experience of pain. A diagnosis is a clinical classification; impairment concerns a bodily function or structure; disability and participation are influenced by personal circumstances and environments; prognosis concerns future trajectories. The WHO International Classification of Functioning supplies a recognized language for assessing health and its functional consequences. This broader health framework helps explain why two people with similar diagnostic codes can experience different work interruption, home-care requirements or reintegration difficulties.
The NSW permanent-impairment rules make the differentiation unusually explicit. They define impairment as alteration of health status and distinguish it from resulting disability; they specify assessment using records, clinical examination and a reasoned percentage determination. The relevant rules apply to accidents from December 1, 2017, while earlier accidents may fall under earlier guidelines. An impairment percentage in this system is a legally relevant measurement, not a universal dollar equivalent of suffering, future wages, or total social loss. Its evidentiary weight depends on the scheme and the claimed category of benefit.
The newest SIRA guidelines, version 10.2, commenced November 6, 2026. The authority identifies transitional exceptions for pre-April 2023 accidents and for certain policies in a defined 2026–2027 period. Using a 2026 guidance page without examining these transitional conditions would create a version error. Permanent impairment is evaluated under the relevant temporal framework, and a prognosis should recognize that stabilization of impairment and stabilization of future treatment requirements need not coincide.
A defensible evidentiary record
A systematic injury assessment links the event, clinical course and documented economic consequences. At a minimum the research record should identify the crash and alleged mechanism, initial symptom onset, emergency and subsequent clinical findings, imaging or other diagnostics where relevant, treatment chronology, prior conditions relevant to causation, functional limitations, work restrictions, rehabilitation goals, anticipated treatment, and records capable of verifying costs. The purpose is to establish an evidence chain, not to equate absence of a diagnostic image with absence of injury. Clinical documentation should be judged according to the condition and its established diagnostic standards.
Causation questions arise at two levels. Medical reasoning asks whether the event could have contributed to the observed condition and whether competing explanations fit the record. Legal reasoning asks whether the injury and compensable losses satisfy the jurisdiction's operative causation standard. The SIRA causation guidance expressly separates clinical inference from the additional legal judgment and recognizes multiple contributing causes. Where a claimant had a preexisting condition, the analysis must distinguish baseline impairment from accident-related aggravation using dated evidence. Neither the insurer nor the medical expert should transform a plausible mechanism into a factual finding without examining contradictory information.
Evidentiary uncertainty can be documented as an explicit range. Suppose available clinical reports support two future treatment scenarios: a 40% possibility of short-term rehabilitation and a 60% possibility of prolonged rehabilitation. These percentages are hypothetical assumptions, not published clinical probabilities; they may illustrate decision sensitivity but do not replace expert prognosis. Proper clinical assessment should state whether the probabilities are empirically calibrated, based on observed cohorts, or merely scenario weights. A settlement valuation that conceals uncertain future treatment as one exact figure overstates the precision of the evidence.
Economic losses and their measurement
Medical expenses include past treatment charges and, where legally compensable, future costs of appropriate services, assistive technologies, medication, therapy and rehabilitation. The legally recoverable amount may be limited by necessity, reasonableness, fee schedules, collateral-source rules or coordination requirements. Wage loss concerns employment-related earnings that would have occurred without the injury, adjusted for actual capacity and applicable legal tests. Future earning-capacity loss must distinguish projected income from earnings actually paid, and must not add the same income stream twice under different labels.
Let the future compensable care flow at time t be C_t, the permitted wage-loss flow be W_t, an assumed discount rate be r_t, and a survival or service-use factor be q_t. A simplified illustrative present value is
This expression is an accounting of assumptions, not a universal legal damages measure. Jurisdictions may prescribe discount rates, multiplier tables, periodic payment methods or distinct treatment of inflation, mortality, taxes, contingencies and public benefits. A nominal cash-flow forecast should use a nominal discount rate consistently; a real forecast should use a real rate. The calculation should retain scenario-level output for future care, earnings, and other categories rather than compressing the original evidence into a single unexplained number.
Consider a hypothetical claimant whose compensable treatment and rehabilitation are assessed at $24,000, past net earnings loss at $16,000, and future earnings interruption at $12,000 in present-value terms. If the applicable law also permits an independently assessed $8,000 for non-economic harm, a provisional sum before liability adjustments, benefit offsets, statutory ceilings and costs is $60,000. The example merely demonstrates component reconciliation: 24,000 + 16,000 + 12,000 + 8,000 = 60,000. No part of it is a statistically typical motor injury award; the lawful treatment of non-economic damages, medical expenses and offsets differs by jurisdiction.
A second hypothetical isolates discount sensitivity. A guaranteed $10,000 payment at the end of each of five years has present value approximately $45,797 at a 3% constant annual discount rate and $43,295 at 5%. The difference, about $2,502, arises solely from the rate assumption. For a long-lived care requirement, assumptions concerning rehabilitation duration, price growth, mortality, technology and the timing of needs can have larger effects. These hypothetical values assume annual year-end payments, no inflation and no contingent survival variation; they cannot be imported into a live court valuation without legal and actuarial validation.
Clinical outcomes as evidence, and the risk of selective inference
Prospective studies demonstrate why settlement assessment must be cautious about simple injury labels. In an Australian cohort, Rebbeck and colleagues (2006) studied whiplash-associated disorders and reported increasing functional recovery over two years within its recruited group, with substantial heterogeneity in outcomes. The study concerns people with compensable whiplash injuries in New South Wales; extrapolating its estimates to severe traumatic brain injury, spinal cord injury, all road users, or another legal system is unwarranted.
A study by Sterling, Hendrikz, and Kenardy (2010) followed 155 individuals after whiplash and identified distinct pain/disability and posttraumatic-stress symptom trajectories. It reported associations between compensation claim lodgment and several trajectories, with differences across outcome classes. The original study's observational design and time-varying exposure deserve attention: the association does not by itself identify the causal effect of making a claim. Claim submission may be influenced by symptom persistence, resources, access to advice and the very health outcomes being tracked.
The scientific implication is that injury valuation should use patient-specific documented evidence, explicit uncertainties and legally required standards while recognizing the heterogeneity observed in cohorts. An impairment estimate, a claim's legal status and a prognosis each supply different information. None is a reliable substitute for the others.
Claimant Representation and Delay
Representation as a response to case complexity
Claimant representation can supply knowledge of legal rights, access to expert evidence, negotiation resources and protection against inadequately explained releases. It can also introduce professional fees, procedural steps and bargaining strategies. The relationship between representation and settlement delay therefore has several plausible directions. Individuals with more serious injuries, disputed liability, greater future-care uncertainty or more valuable claims may be especially likely to seek representation. Those same factors independently lengthen investigation and settlement. Comparing represented and unrepresented claims without adjusting for selection can mistake an effect of case complexity for an effect of representation.
The causal structure can be expressed informally: severity and uncertainty influence both the choice of representative and time to closure; representation may separately affect evidence quality, the number of expert reports, negotiation posture, settlement value, and timing. The difficulty is that data often contain only a flag for whether counsel was engaged at some point. A claimant who engages a lawyer after an insurer's prolonged denial may be recorded as represented, although delay preceded representation. The correct design treats the date of engagement as a time-varying event, separates pre-engagement duration from later time, and measures reasons for engagement where reliable data permit.
In an Australian prospective cohort, Casey, Feyer, and Cameron (2015) examined duration of compensation following whiplash in a fault-based third-party scheme. Of 246 participants, 25% were in the compensation system longer than 24 months and 15% longer than three years. Both health-related and insurance-related factors were associated with duration. Shorter closure was associated with absence of legal involvement in the reported model; this association cannot show that assigning an otherwise comparable claimant a lawyer would itself increase delay. The study concerns one injury group and one scheme, and its time-to-closure outcome should not be equated with medical recovery.
The NSW claims conduct requirements address communication with claimants and representatives directly. The applicable guidelines provide for communication rules even where a claimant has legal representation. This illustrates a substantive governance principle in an operative setting: engaging an adviser should not make the process opaque to the person whose injury and benefits are being assessed. For researchers, it also creates distinct observable dates for contact, response and notification that can be examined independently of legal-engagement status.
Measuring delay correctly
The term settlement delay is ambiguous unless its start and end dates are fixed. Accident-to-report delay measures access to the insurance or compensation system; report-to-initial-decision delay measures early administrative performance; decision-to-offer delay measures negotiation or evidence development; offer-to-payment delay measures execution; and crash-to-closure aggregates all stages. These intervals have different distributions and are sensitive to whether the sample includes only finalized cases.
An analysis should identify which cases are still open at the data extraction date. For a claim that is open at time T, closure time is right-censored rather than observed as equal to T. Claims closed earlier can be overrepresented in a simple dataset of completed settlements. Survival methods, with careful treatment of evolving injury severity and representation, can estimate the hazard of closure while preserving censoring. If a dataset starts at the first report rather than at the crash, delayed reporting may introduce left-truncation or selection problems. Cross-jurisdictional comparisons must use consistent definitions of closure: the last insurer payment, closing an administrative record and a legally enforceable full-and-final release may occur on different days.
To illustrate the distinction, suppose 100 claims are reported in January and 50 close within 90 days. If the remaining 50 are open at the end of the observation period, calling the cohort's average closure time 90 days from the 50 completed cases is invalid. It describes only those already closed. A proper survival or restricted-mean analysis should incorporate the open cases, their observed follow-up and an explicit cutoff. In a scheme with continuing medical benefits, a legal damages settlement can coexist with open treatment reimbursement, making one overall case-closed indicator especially misleading.
Published empirical results show the danger of substitution. Boyle and colleagues (2017) studied a prospective cohort with whiplash-associated disorders in a no-fault motor insurance context. Mean claim closure occurred at 291 days while mean self-reported recovery occurred at 134 days. Closure was associated with recovery-related measures, but its timing substantially exceeded reported recovery. The result shows why an insurer's closing date can be informative as a process outcome while remaining an imperfect proxy for a health outcome. The two means come from the study cohort and should not be treated as a universal motor-claims benchmark.
Informational bargaining and settlement pressure
An injured claimant may know pain, treatment burdens and work restrictions better than an insurer, while the insurer may know policy provisions, claim valuation distributions and dispute outcomes better than the claimant. Medical experts and legal representatives can narrow some information gaps but may also disagree over causation and prognosis. There are additional asymmetries when a claimant faces immediate income interruption and the payer has financial resources to fund prolonged negotiation. The relevant concern is the content and timing of information supplied before a binding settlement.
A simple stylized bargaining comparison helps clarify the issue. Let G denote the gross settlement, F any contingent professional fee, K outstanding recoverable medical liens or reimbursements, and X the claimant's unreimbursed costs. The net amount received for remaining needs is N = G − F − K − X. A gross offer of $80,000 with a hypothetical fee of $20,000, repayable obligations of $12,000 and claimant costs of $3,000 leaves $45,000. An offer framed solely as an $80,000 award hides substantial differences in actual disposable proceeds. Whether each deduction is lawful or actually payable is a separate jurisdictional and contractual question, not determined by the arithmetic.
A claimant's liquidity need can produce an incentive to accept a smaller prompt payment even where the expected litigated entitlement is larger. Comparing options should therefore account for the timing of funds, litigation expense, probability of recovery, ability to bear uncertainty, interim benefits, interest, and the legal scope of the release. It is analytically inadequate to describe acceptance as voluntary solely because a signature appears on a discharge form; the surrounding availability and comprehension of alternatives are relevant empirical facts. Conversely, longer litigation does not necessarily improve welfare once costs and uncertainty are included.
The EU reasoned-offer and reply procedure supplies a concrete institutional response to delay and asymmetry. Article 22 requires a reasoned offer within three months of the claimant's presentation where liability is not contested and damages are quantified, or a reasoned reply where liability remains disputed or damages are not fully quantified. The requirement is for an offer or reply under the stated conditions, not automatic full settlement of every unquantified medical claim within three months. This precision is essential to assessing regulator compliance.
Represented claimants and health outcomes
Research on the compensation process also asks whether procedural exposure affects recovery, and whether recovery drives the process. These are different causal pathways that are difficult to separate observationally. Sterling and colleagues (2010) observed associations between claim lodgment and health trajectories among participants with whiplash; their design cannot exclude selection by symptom development or other unmeasured factors. Casey and colleagues (2015) found predictors of prolonged closure that included both initial health and claim-process characteristics. Neither result licenses a general presumption about the accuracy of individual claimants' symptom reporting.
A separate longitudinal test by Spearing and colleagues (2012) examined whether settlement of fault-based whiplash claims was followed by an abrupt change in reported neck pain. Their analysis found no support for a hypothesized disappearance of self-reported pain at settlement. This study directly cautions against assuming that ending financial incentives necessarily eliminates symptoms. The result is specific to its data, injury type, time horizon and measured outcome; it should be interpreted together with clinical evidence rather than substituted for individual injury assessment.
Researchers should distinguish three propositions: compensation processes may alter stress and behavior; injured people may select into formal claims depending on their health; and some individual claims may contain errors, exaggerated elements or fraud. Evidence for one does not establish the prevalence or mechanism of the others. The research record should identify actual objective misstatement evidence rather than infer dishonesty from representation, prolonged symptoms or a claim's financial value.
Settlement Sufficiency and Fairness
The meaning of a sufficient settlement
Settlement sufficiency has more than one dimension. Legal sufficiency concerns whether the amount and form satisfy an enforceable entitlement under the governing rules. Financial sufficiency concerns the resources remaining for eligible treatment, income replacement, care and other future consequences. Procedural sufficiency concerns whether the claimant was given understandable information, adequate access to records and a fair opportunity to contest disputed facts. Temporal sufficiency concerns whether compensation arrives when needed and whether appropriate interim payments are available. Empirical assessment must observe these dimensions separately rather than classify every formally executed release as a successful outcome.
For an injury that remains medically unstable, a final lump-sum discharge may transfer future prognostic uncertainty from an insurer to the claimant. An adequately funded payment or legally permitted periodic benefit can instead allocate that risk differently. This is particularly important for progressive conditions, permanent dependency, long-term treatment and changing functional capacity. When a jurisdiction restricts early damages settlements or makes certain benefit classes continuing obligations, the restriction is part of the entitlement design. Analysis should ask whether the settlement covers foreseeable consequences under the law and evidence available at decision time, not whether subsequent outcomes happened to match a point estimate exactly.
The current SIRA claims guidelines contain provisions on reasonable settlement offers, quantification after recovery and review or dispute rights. For a specified request to concede a permanent-impairment level greater than 10%, the guidelines state acknowledgment and decision timing requirements. These procedural measures demonstrate that settlement fairness can be investigated through documents, response dates and disclosed reasoning, rather than through subjective satisfaction scores alone. The precise threshold and timeframes are jurisdiction-specific.
The general FCA requirement of fair claims handling provides another comparison, but its scope must be examined carefully for the type of claim, insured and claimant. A broad phrase such as prompt and fair handling cannot by itself establish which damages are payable, which person can sue, or the date at which a third-party medical condition is sufficiently stable for final valuation.
A decomposition of the settlement amount
Let D be gross damages legally recoverable on an agreed or adjudicated basis, A be any legally applicable allocation for responsibility or contributory factors, O be allowable offsets and coordination, M be relevant policy or statutory limits, and P be payments already made that must be credited. A schematic maximum outstanding insured payment is
This schematic is not an operative legal formula. Some systems apply limits before offsets, separate different heads of damage, permit costs and interest outside limits, prohibit some deductions, or provide first-party benefits without a liability allocation. It therefore functions only as a checklist of variables that must be assessed in the correct jurisdictional order. A settlement amount can equal a lawful coverage limit even when the claimant's demonstrated future losses exceed the insurer's obligation. In that circumstance the legal insured payment may be complete while the injured person's economic restoration remains incomplete.
Consider a hypothetical third-party claim with assessed damages of $120,000. Suppose, solely for illustration, a jurisdiction permits a 20% responsibility adjustment, no offsets or prior payments apply, and the relevant liability insurance layer is limited to $75,000. The adjusted damages would be $96,000, while the modeled insurer payment would be $75,000. The resulting $21,000 gap is an uninsured or excess exposure in this simplified example. It is not a judgment that the claimant has waived rights against another payer or liable party. Actual policy wording, statutory protections, priority rules and litigation outcomes determine what happens to any residual loss.
Net settlement adequacy requires another calculation: if the $75,000 gross payment carries permitted costs, reimbursements and outstanding medical obligations, the resources remaining to meet future needs can be materially lower. A researcher should reconstruct the full money path, recording amounts paid directly to providers, claimant receipts, subrogated recoveries and future obligations separately. A claims dataset that records only insurer indemnity paid cannot answer the question of claimant net compensation without linking additional records.
Comparison of compensation regimes
| Regime or source | Principal injury-payment logic | Characteristic settlement issue |
|---|---|---|
| United States motor liability and first-party covers | State-specific tort, medical-payments, PIP and uninsured-motorist triggers | Eligibility and coordination depend on applicable state and policy; gross liability awards cannot stand in for PIP benefits |
| European Union compulsory third-party motor liability | Direct action and procedural protections; member-state damages law remains material | Reasoned-offer or reply compliance and the separation between liability, quantification and final payment |
| Great Britain motor third-party cover | Compulsory protection for qualifying liabilities and specified insurer judgment obligations | Scope of insured liability and enforceable recourse, with separate conduct and civil-procedure regimes |
| New South Wales CTP motor injuries | Statutory benefits, damages pathways, injury thresholds, assessment and dispute procedures | Accident-date transition rules, clinical impairment assessments and timing of quantified reasonable offers |
| Japan compulsory CALI plus voluntary insurance | Defined per-victim compulsory bodily injury layer and supplementary arrangements | Distinguishing compulsory payment maxima from total lawful damages and access to provisional payments |
| New Zealand accident compensation | Statutory injury benefits with constraints on ordinary covered-injury damages suits | Measuring treatment and income replacement rather than only tort lump-sum settlements |
The underlying legal and operational records are the EU motor-insurance directive, the Great Britain compulsory policy rule, the NSW assessment guidelines, the Japanese CALI compensation description, the NAIC coverage categories, and the New Zealand ACC income-support guidance. The table summarizes institutional differences; it does not assign a numerical fairness ranking to countries.
Insolvency, uninsured drivers and effective payment
A theoretical legal entitlement does not ensure actual financial recovery if the driver is uninsured, the insurer fails, or an obligated entity cannot pay. EU rules establish compensating bodies for circumstances including unidentified or uninsured vehicles. Directive (EU) 2021/2118 adds protections addressing insurer insolvency. The existence of such arrangements affects the probability and timing of payment, but eligibility, subrogation and institution-specific administration must be separately verified in the relevant member state.
Japan likewise operates a government program for qualifying victims of uninsured and hit-and-run vehicles, as described in the MLIT victim-protection framework. This program is analytically distinct from voluntary insurance and the compulsory CALI contract. Where a claimant has access to more than one responsible institution, the assessment should map payment sequence, reimbursement rights and deadlines before declaring a loss uncollectible.
These arrangements imply a practical fairness distinction: the nominal size of compensation and the expected probability that the compensation will actually be paid should be measured separately. A claimant with a large unenforceable award may be less financially protected than one whose smaller statutory entitlement is funded and promptly administered. Any empirical comparison must avoid translating this analytical point into an unsupported numerical ranking without payment-realization data.
Discharge, informed agreement and continuing obligations
Full-and-final settlement language can cover known and unknown future consequences within the permitted legal scope, but jurisdictions differ over enforceability, approval for minors or persons lacking capacity, statutory benefit continuation, reopening rights and mistakes. Scientifically meaningful assessment requires the full settlement instrument, not merely a payment receipt. The record should identify whether liability is admitted, what claims are released, how costs and liens are handled, whether future treatment is preserved or closed, whether the claimant had access to advice, and the signature, funding and release dates.
Settlement outcomes should therefore be classified at several levels: agreement reached, money transferred, statutory benefit discharged, civil action extinguished, and residual care needs funded. They are separate events. A case described as successfully closed because a release was signed may still reveal poor financial adequacy if the claimant's net future care resources are inadequate; alternatively, an open continuing benefit file may be working exactly as the statutory system intends. In each case, conclusion requires evidence under the law actually governing the claimant.
Comparative Evidence, Data Uncertainty, and Validation
The unit of observation and compatible data definitions
Reproducible claim science begins with a data dictionary. A crash may involve several injured people; one person may have multiple coverage claims; and one insurer may record separate benefits and liability files. The recommended primary key combines pseudonymized crash, person, coverage and jurisdiction IDs. Additional fields should include vehicle and road-user class, accident and policy dates, date of knowledge or notice, injury type and clinical assessments, benefit category, liability decision, representation engagement, each offer and counteroffer, the date and form of discharge, payments by recipient, reserve updates, and legally allowed medical or wage offsets.
The WHO functioning classification helps distinguish health and participation measures from financial records. An injury category should also retain coding version and the assessment date. Linking administrative records to clinical outcomes requires appropriate confidentiality safeguards and an explicit definition of the population to whom results apply. The mere availability of a payer dataset does not mean all crash victims or all injuries are included. People with unreported injuries, inaccessible coverage, claims rejected before formal registration or treatment funded entirely elsewhere may be systematically absent.
For every cohort, specify accident years, reporting years, calendar years of payments, closure observation horizon, jurisdiction, injury severity and monetary basis. Nominal severities from different years should be compared using transparent inflation treatment and case-mix controls. A change in the proportion of severe traumatic injuries can raise mean paid severity even if category-specific treatment prices are stable. Similarly, changes in liability limits, medical schedules or legal filing behavior can alter the sample of recorded claims without a change in crash injury biology.
Legal and regulatory version control
Regime changes should be represented as dated exposures. Under the EU amending motor-insurance directive, adoption, transposition and application have distinct legal dates; national implementing measures should be checked before drawing country-specific compliance conclusions. In Great Britain, the 2026 point-in-time section 145 text records the legal view selected for this analysis; earlier accidents can require earlier legislative versions and judicial decisions.
In New South Wales, version 10.2 of the guidelines is dated November 6, 2026 and expressly preserves earlier provisions for specified claims and policy dates. An analyst assigning the current guideline uniformly to a 2020 crash or every 2026 policy can misclassify the legal procedure. Correct cohort construction therefore uses accident and policy inception dates and any temporal exceptions alongside claim reporting and settlement dates.
Statistical identification and selection bias
A standard cross-sectional comparison of mean settlement values among represented and unrepresented claimants is subject to confounding by injury severity, disputed liability, expected damages, claimant resources and prior claim history. A basic regression such as log(payment) = α + β representation + γ severity + ε has no automatic causal interpretation. Representation may begin after negotiation problems arise, severity may be measured with error, and log(payment) excludes zero-payment claims unless separately modeled. Selection into the filed-claim population and into settlement without trial can further distort the observed contrast.
The design can be improved by recording representation as a time-varying exposure, separating pre- and post-engagement periods, using baseline injury measures recorded before counsel engagement, documenting admissible controls, and conducting sensitivity analyses for unmeasured factors. Some research questions may permit a policy reform or administrative assignment rule to serve as quasi-experimental variation, but such an identification strategy must be justified with the reform's actual content, timing, affected population and assumptions. This manuscript claims no identified causal effect of lawyer engagement, insurer negotiation strategy or compensation receipt because it does not have such an exogenous study design or individual-level data.
The distinction is supported by the empirical literature. Casey, Feyer, and Cameron (2015) report health and insurance-related predictors of claim duration, not a randomized experiment in representation. Sterling and colleagues (2010) report trajectory associations after claim lodgment, again in an observational cohort. Spearing and colleagues (2012) address a more specific hypothesis about pain changing at settlement. Their different designs, outcomes, and populations support distinct inferences and should never be collapsed into the general proposition that compensation causes poor recovery.
Claims closure, costs and actuarial liabilities
Insurer accounting and reserving record expected future payments, while clinical outcome studies record physical, psychological and functional consequences. The IFRS 17 description of insurance contracts states that groups of contracts are measured using current estimates of future cash flows and a risk adjustment under the standard's framework. The IFRS 17 key terms identify the liability for incurred claims as an obligation to pay amounts related to services already provided. These accounting concepts matter because settlement cost can continue to develop after a claim has been reported, and the adequacy of an insurer's portfolio liability depends on case estimates, unreported claims and statistical development uncertainty.
A simplified portfolio decomposition may be written as expected total cost = expected claim count × expected ultimate payment per claim, refined by coverage, injury severity, jurisdiction and accident year. For reported bodily injury claims, ultimate payment is observable only after sufficient development, and open claims must be valued using assumptions. Claim-level reserve adequacy does not establish individual fairness, and claimant-level fairness does not directly establish portfolio reserve adequacy. They answer different questions, although systematic underassessment or delay can affect both ultimate costs and the distribution of compensation.
Suppose 1,000 hypothetical reported claims have $12 million paid and $5 million in estimated outstanding future indemnity and allocated expense. The indicated total on those assumptions is $17 million. This figure does not include any unreported or reopened cases unless the outstanding component explicitly does so. If $2 million in additional provision is estimated for incurred but not reported claims, a broader illustrative incurred position becomes $19 million. Such arithmetic is not an actuarial opinion about any actual insurer and does not demonstrate compliance with IFRS 17, which requires a more detailed measurement framework.
Robustness and evidence-quality checks
A credible empirical assessment should compare alternative definitions of injury severity, retain a distribution rather than mean alone, report separately the share of claims with zero payment and very large payment, and test whether conclusions change with inflation adjustments, legal regime, exposure period, reporting delay and development maturity. Important robustness checks include administrative closure versus legal discharge, separate medical recovery dates, legal representation measured at reporting versus time varying, and net claimant proceeds versus insurer gross payment.
The difference between closure and recovery is directly observed in Boyle and colleagues (2017). Additional Rebbeck and colleagues (2006) evidence of heterogeneous recovery among whiplash claimants reinforces the need to examine outcome distributions instead of treating settlement timing as a clinical endpoint. Both are injury-specific cohort records: neither establishes general insurer conduct prevalence, national claims severity or a universally optimal claim duration.
The evidence inventory used here is bounded. Official primary rules establish categories and identified obligations; clinical cohort papers establish sample-level findings; transparent formulas establish only sensitivity to named assumptions. The monograph has no confidential claim-level dataset, original patient enrollment, randomized intervention, field audit of insurer files, expert medical diagnosis or external peer-review report. Those absences are material boundaries on statistical and causal claims, not unfinished bibliographic checks. No market severity estimate or policy intervention effect is claimed.
Integrated Results and Open Research Questions
A reconstruction of a complete claim assessment
The comparative record supports a sequential analytical account of motor bodily injury settlement. First, define the person, crash, policy and governing legal version. Second, document injury and the clinical trajectory, including preexisting conditions and functional consequences. Third, identify entitlement under the correct legal pathway: tort liability, direct action, first-party benefits, compulsory statutory coverage or social injury protection. Fourth, separately value past losses, future expense streams, income loss and any eligible non-economic harm. Fifth, establish which institution pays each component and whether limits, offsets or priority rules apply. Sixth, document offers, response reasons, representation, claimant information and final release scope. Seventh, examine actual payment and subsequent access to care or support. This sequence is a synthesis of existing evidence requirements and institutional structures, not a newly proposed legal doctrine.
Medical assessment, legal recovery and cash settlement should be reconciled through traceable documents. A clinical report alone cannot establish insurance payment responsibility; a liability admission alone cannot quantify future impairment; a statutory benefit schedule alone cannot show the claimant's complete economic burden; and a case reserve alone cannot demonstrate full and fair compensation. These separations clarify why bodily injury claim science is inherently interdisciplinary and why simple settlement averages are not sufficient evaluative indicators.
Findings supported by source comparison
The principal findings are as follows. Insurance coverage architecture determines which losses are potentially claimable and who may pay; NAIC coverage distinctions and Japanese CALI payment limits provide direct examples. Legal systems distribute responsibility for timing and recourse differently; the EU Article 22 procedure specifies a three-month reasoned offer or response obligation under its conditions, while the NSW claims-guideline procedure articulates more detailed operational steps. Permanent impairment requires an applicable medical-legal measure, as illustrated by SIRA's assessment rules.
Clinical recovery and administrative closure are empirically separable: Boyle and colleagues (2017) measured materially different mean times in a prospective whiplash cohort. Representation and duration display observational associations that require selection-aware analysis, as demonstrated by Casey and colleagues (2015). The idea that settlement itself abolishes reported pain is contradicted in the studied cohort by Spearing and colleagues (2012). These results justify using distinct measurement systems and avoiding simplistic judgments about claimant behavior.
Settlement fairness consequently comprises several observable features: legal eligibility accuracy, evidentiary adequacy, reasoned communication, timely process, claimant comprehension of releases, realization of payment, and resources retained for legitimately compensable future needs. A claim can score differently along these dimensions. The conclusion is an analytical synthesis, not a claim that these dimensions have been validated as a universal psychometric scale or constituted as a new theory.
Priority research questions
A future linked-data study could test whether required reasoned-offer mechanisms reduce avoidable delay for otherwise comparable claims after accounting for changing case mix and legal implementation dates. Another could examine whether initial prognostic quality improves the calibration of future-care settlements, measuring both overpayment and unmet clinically justified needs under fixed statutory terms. A third could compare net claimant proceeds, rather than insurer gross payment, across represented and unrepresented claimants, retaining actual engagement dates and controlling for baseline severity and preexisting dispute. A fourth could examine whether case closure is an acceptable surrogate for physical recovery only within specific injury classes and benefit systems. Each question requires preregistered definitions, access to appropriate records and a defensible identification design.
International research should also measure the degree to which statutory benefit systems affect the observed distribution of private bodily injury settlements. In New Zealand, ACC income-related support and limits on ordinary covered-injury litigation supply an institutional contrast to many tort schemes. In the EU, insolvency-victim protection amendments make the solvency and enforceability of compensation relevant in their own right. Cross-country datasets should keep separate measurements of the claimant's total harm, statutory benefits, private-insurance payments, state-supported payments, claim handling expense and unpaid needs. Otherwise an apparently low mean motor-liability settlement could be a consequence of care funded through another program rather than evidence of inadequate or superior protection.
Research limitations and provenance
This work synthesizes public statutes, official standards and primary published empirical studies verified for this manuscript on November 16, 2026. It makes no claim to have inspected confidential settlement files, insurer correspondence, medical examinations, original court case bundles or individual claimant releases. Legal propositions are qualified by the published text and its date and remain subject to fact-specific national implementation and interpretation. The numerical scenarios are invented solely to test calculation structure, not observed insurance data or proposed settlement offers. The linked clinical studies predominantly concern whiplash and cannot establish long-term prognosis for every kind of road injury.
The internal authorial contribution is the source-specific comparison of measurement systems, chronology, causal identification, financial netting and final discharge, together with explicit conditions under which each inference is valid. The factual and bibliographic claims are traceable to the publications listed below and mapped in EVIDENCE.json. This synthesis neither asserts an original school of claims theory nor claims external peer validation.
Conclusion
Motor bodily injury claim assessment is a reconstruction of the relationship between a road event, demonstrable health consequences, legally recognized loss, insurance or statutory entitlement and the final transfer of benefits. A defensible settlement follows from precise identification of the applicable regime, evidence proportionate to the claimed consequences, transparent valuation of present and future losses, justified allocation among payers, documented communication and a clear account of what rights are discharged. The total injury burden, the legally recoverable amount, the insurer's capped payment, the amount received by the claimant and the actuarially expected ultimate cost can diverge substantially without contradiction.
Comparative primary sources establish both common objectives and important institutional diversity. The EU framework provides direct action and reasoned settlement procedures; Great Britain's compulsory third-party rules govern particular legal obligations; New South Wales specifies medical and claim-administration processes with dated transitional rules; Japanese CALI supplies defined compulsory bodily injury protection; the United States combines multiple state-dependent coverage forms; and New Zealand organizes significant injury support through statutory accident compensation. A meaningful comparison must follow actual claimant resources and enforceable obligations across all relevant institutions rather than compare only the face value of private settlements.
The clinical evidence further establishes the need to distinguish injury prognosis from administrative outcomes. Prospective whiplash research demonstrates heterogeneous recovery, associations between compensation procedures and duration, and differences between the time of recovery and the time of formal closure. These studies motivate better causal research without proving general effects of representation or settlement on health. The strongest scientific conclusion is methodological and operational: transparent claim-level chronology, source-specific legal versioning, separation of health and finance metrics, and careful treatment of selection and censoring are indispensable to reliable assessment of motor bodily injury settlement outcomes.
References
Boyle, Eleanor, J. David Cassidy, Pierre Côté, and Linda J. Carroll. 2017. “The Relationship Between Insurance Claim Closure and Recovery After Traffic Injuries for Individuals With Whiplash Associated Disorders.” Disability and Rehabilitation 39 (9): 889–896. https://pubmed.ncbi.nlm.nih.gov/27207822/ . DOI: 10.3109/09638288.2016.1170211.
Casey, Petrina P., Anne Marie Feyer, and Ian D. Cameron. 2015. “Associations With Duration of Compensation Following Whiplash Sustained in a Motor Vehicle Crash.” Injury 46 (9): 1848–1855. https://pubmed.ncbi.nlm.nih.gov/26129637/ . DOI: 10.1016/j.injury.2015.06.018.
European Parliament and Council. 2009. “Directive 2009/103/EC Relating to Insurance Against Civil Liability in Respect of the Use of Motor Vehicles, and the Enforcement of the Obligation to Insure Against Such Liability.” Official Journal of the European Union L 263 (October 7). https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32009L0103 .
European Parliament and Council. 2021. “Directive (EU) 2021/2118 Amending Directive 2009/103/EC Relating to Insurance Against Civil Liability in Respect of the Use of Motor Vehicles.” Official Journal of the European Union L 430 (December 2): 1–23. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021L2118 .
Financial Conduct Authority (FCA). 2025–2026 consolidated view. “Insurance: Conduct of Business Sourcebook, ICOBS 8.1: Insurers—General.” Accessed November 16, 2026. https://handbook.fca.org.uk/handbook/icobs8?date=16-08-2026&timeline=true .
International Association of Insurance Supervisors (IAIS). 2024. “Insurance Core Principles and Common Framework, Updated December 2024.” Institutional standard-setting overview. https://www.iais.org/activities-topics/standard-setting/icps-and-comframe/ .
International Financial Reporting Standards Foundation (IFRS Foundation). 2023. “IFRS 17 Insurance Contracts.” Standard effective for reporting periods beginning January 1, 2023. https://www.ifrs.org/issued-standards/list-of-standards/ifrs-17-insurance-contracts/ .
International Financial Reporting Standards Foundation (IFRS Foundation). n.d. “IFRS 17 Insurance Contracts—Key Terms.” https://www.ifrs.org/supporting-implementation/supporting-materials-by-ifrs-standards/ifrs-17/key-terms/ .
Ministry of Land, Infrastructure, Transport and Tourism (Japan, MLIT). n.d. “Overview of Compulsory Automobile Liability Insurance and Mutual Aid.” https://www.mlit.go.jp/jidosha/jibaiseki/en/about/overview/index.html .
Ministry of Land, Infrastructure, Transport and Tourism (Japan, MLIT). n.d. “Government's Program Guaranteeing Compensation for Automobile Accidents.” https://www.mlit.go.jp/jidosha/jibaiseki/en/public_payment/index.html .
National Association of Insurance Commissioners (NAIC). n.d. “Auto Insurance.” https://content.naic.org/insurance-topics/auto-insurance .
New South Wales State Insurance Regulatory Authority (SIRA). 2026. “Motor Accident Guidelines, Version 10.2 (Effective November 6, 2026).” https://www.sira.nsw.gov.au/resources-library/motor-accident-resources/publications/for-professionals/motor-accident-guidelines .
New South Wales State Insurance Regulatory Authority (SIRA). 2026. “Motor Accident Guidelines: Part 4, Claims.” https://www.sira.nsw.gov.au/resources-library/motor-accident-resources/publications/for-professionals/motor-accident-guidelines/part-4-of-the-motor-accident-guidelines-claims .
New South Wales State Insurance Regulatory Authority (SIRA). 2026. “Motor Accident Guidelines: Part 6, Permanent Impairment.” https://www.sira.nsw.gov.au/resources-library/motor-accident-resources/publications/for-professionals/motor-accident-guidelines/part-6-of-the-motor-accident-guidelines-permanent-impairment .
New Zealand Accident Compensation Corporation (ACC). n.d. “Weekly Compensation for Employees.” https://www.acc.co.nz/im-injured/financial-support/weekly-compensation/weekly-compensation-for-employees .
New Zealand Parliament. 2001, cited statutory version. “Accident Compensation Act 2001, Section 317, Proceedings for Personal Injury.” New Zealand Legislation. https://www.legislation.govt.nz/act/public/2001/0049/127.0/DLM100902.html .
Rebbeck, Trudy, Doungkamol Sindhusake, Ian D. Cameron, G. Rubin, Anne-Marie Feyer, J. Walsh, M. Gold, and W. N. Schofield. 2006. “A Prospective Cohort Study of Health Outcomes Following Whiplash Associated Disorders in an Australian Population.” Injury Prevention 12 (2): 93–98. https://pmc.ncbi.nlm.nih.gov/articles/PMC2564458/ . DOI: 10.1136/ip.2005.010421.
Spearing, Natalie M., Dorte Gyrd-Hansen, Louis H. Pobereskin, David S. Rowell, and Luke B. Connelly. 2012. “Are People Who Claim Compensation ‘Cured by a Verdict’? A Longitudinal Study of Health Outcomes After Whiplash.” Journal of Law and Medicine 20 (1): 82–92. https://pubmed.ncbi.nlm.nih.gov/23156650/ .
Sterling, Michele, Joan Hendrikz, and Justin Kenardy. 2010. “Compensation Claim Lodgement and Health Outcome Developmental Trajectories Following Whiplash Injury: A Prospective Study.” Pain 150 (1): 22–28. https://pubmed.ncbi.nlm.nih.gov/20307934/ . DOI: 10.1016/j.pain.2010.02.013.
United Kingdom Parliament. 1988, point-in-time text June 29, 2026. “Road Traffic Act 1988, Section 145: Requirements in Respect of Policies of Insurance.” https://www.legislation.gov.uk/ukpga/1988/52/section/145/2026-06-29 .
United Kingdom Parliament. 1988, current online consolidated text. “Road Traffic Act 1988, Section 151: Duty of Insurers to Satisfy Judgment Against Persons Insured.” https://www.legislation.gov.uk/ukpga/1988/52/section/151 .
World Health Organization (WHO). 2001, with subsequent updates. “International Classification of Functioning, Disability and Health (ICF).” https://www.who.int/classifications/international-classification-of-functioning-disability-and-health .
World Health Organization (WHO). 2023. Global Status Report on Road Safety 2023. Geneva: WHO. ISBN 978-92-4-008651-7. https://www.who.int/publications/i/item/9789240086517 .